Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevudine in HBeAg-Positive Chronic Hepatitis B
NCT00313287Phase 3Terminated
- Sponsor
- Bukwang Pharmaceutical
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clevudine in hepatitis B (HBV), sponsored by Bukwang Pharmaceutical. Started Jun 2003; status: terminated.
02
Drugs
clevudine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00313287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00313287.